$PHVS insider trading
Over the last 12 months, Pharvaris insiders reported no purchases and 26 sales totaling $11.3M across SEC Form 4 filings. 85% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $11.3M 26 events
- Events · 12m
- 26 Form 4 filings, grouped
- Insiders · 12m
- 7 distinct reporters
- 10b5-1 share
- 85% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Modig BerndtChief Executive Officer · O·D | ▼ Sale | 2,292 | $34.77 | $80K | -1.7% | plan |
| Jul 13, 2026 | Modig BerndtChief Executive Officer · O·D | ▼ Sale | 2,292 | $34.97 | $80K | -1.7% | plan |
| Jun 30, 2026 | Schikan Johannes Gerardus Christiaan PetrusD | ▼ Sale | 37,600 | $35.41 | $1.3M | -10.7% | plan · 2 tranches |
| Jun 30, 2026 | Lesage AnneChief Early Development · O | ▼ Sale | 37,700 | $35.41 | $1.3M | -28.6% | plan · 2 tranches · indirect |
| Jun 30, 2026 | Lesage AnneChief Early Development · O | ▼ Sale | 38,472 | $35.37 | $1.4M | -39.6% | plan · 3 tranches |
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan PetrusD | ▼ Sale | 2,400 | $35.1 | $84K | -0.7% | plan |
| Jun 26, 2026 | Lu PengChief Medical Officer · O | ▼ Sale | 29,700 | $34.3 | $1.0M | -31.2% | plan · 3 tranches |
| Jun 25, 2026 | Lesage AnneChief Early Development · O | ▼ Sale | 2,300 | $35.12 | $81K | -1.7% | plan · indirect |
| Jun 25, 2026 | Lesage AnneChief Early Development · O | ▼ Sale | 2,300 | $35.12 | $81K | -3.9% | plan |
| Jun 18, 2026 | Lu PengChief Medical Officer · O | ▼ Sale | 300 | $34 | $10K | -0.5% | plan |
| Jun 15, 2026 | Modig BerndtChief Executive Officer · O·D | ▼ Sale | 2,291 | $31.07 | $71K | -1.7% | plan · 2 tranches |
| Jun 4, 2026 | Nijdam AnnaPrincipal Accounting Officer · O | ▼ Sale | 2,670 | $30.87 | $82K | -5.5% | — |
| May 21, 2026 | Monges VivianeD | ▼ Sale | 9,667 | $30.29 | $293K | -63.7% | — |
| May 21, 2026 | Nijdam AnnaPrincipal Accounting Officer · O | ▼ Sale | 1,829 | $30.6 | $56K | -3.6% | — |
| May 21, 2026 | Nassif David W.CFO / CLO · O | ▼ Sale | 10,000 | $30.31 | $303K | -7.7% | — |
| May 1, 2026 | Lu PengChief Medical Officer · O | ▼ Sale | 14,166 | $30.17 | $427K | -17.7% | plan · 2 tranches |
| Apr 30, 2026 | Schikan Johannes Gerardus Christiaan PetrusD | ▼ Sale | 32,900 | $30.29 | $997K | -8.5% | plan · 3 tranches |
| Apr 30, 2026 | Lesage AnneChief Early Development · O | ▼ Sale | 22,900 | $30.22 | $692K | -14.6% | plan · 2 tranches · indirect |
| Apr 30, 2026 | Lesage AnneChief Early Development · O | ▼ Sale | 25,400 | $30.23 | $768K | -31% | plan · 3 tranches |
| Apr 30, 2026 | Lu PengChief Medical Officer · O | ▼ Sale | 18,733 | $30.21 | $566K | -22.1% | plan · 2 tranches |
| Apr 23, 2026 | Schikan Johannes Gerardus Christiaan PetrusD | ▼ Sale | 7,100 | $30.05 | $213K | -1.8% | plan · 2 tranches |
| Apr 23, 2026 | Lesage AnneChief Early Development · O | ▼ Sale | 7,100 | $30.05 | $213K | -4.3% | plan · 2 tranches · indirect |
| Apr 23, 2026 | Lesage AnneChief Early Development · O | ▼ Sale | 7,600 | $30.05 | $228K | -11.9% | plan · 3 tranches |
| Apr 23, 2026 | Lu PengChief Medical Officer · O | ▼ Sale | 7,101 | $30.05 | $213K | -9.7% | plan · 2 tranches |
| Apr 16, 2026 | Modig BerndtChief Executive Officer · O·D | ▼ Sale | 2,292 | $28.6 | $66K | -1.6% | plan |
| Apr 9, 2026 | Modig BerndtChief Executive Officer · O·D | ▼ Sale | 23,333 | $27.74 | $647K | -14.1% | plan · 2 tranches |
Every $PHVS filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Pharvaris filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $PHVS feed.